A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an ...

A new monoclonal antibody called nebokitug offers fresh hope to patients who have primary sclerosing cholangitis (PSC), ...

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease ...

The AI model analyzes data from routine electrocardiograms (ECGs) at Mayo Clinic. It identifies patterns linked to advanced ...

The National Health Service (NHS) has greenlit a major trial for a “game-changing” device that acts like a dialysis machine, ...

Social media plays an important role in awareness around health and wellness, but sometimes it blurs the line between facts ...

As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...

Mrs Adcock cared for her mum in the final stages of her life and lost her brother-in-law three weeks after a failed liver ...

Experts caution that the booming market for herbal detox teas can pose serious risks, especially for people with existing liver problems.

A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing ...

Altimmune said on Friday its experimental liver disease drug led to weight loss and improved markers for scarring and health of the organ based on non-invasive tests after 48 weeks of treatment in a ...

Liver disease can lead to complications that affect your lungs, such as the buildup of fluid around your lungs or high blood pressure in the arteries that lead to your lungs from your heart. Your ...